miércoles, 10 de julio de 2019

AzurRx Launches Trial Testing MS1819-SD Combined With PERT for CF

AzurRx Launches Trial Testing MS1819-SD Combined With PERT for CF

Cystic Fibrosis News Today

AzurRx BioPharma Launches Phase 2 Trial Testing MS1819-SD Combined With PERT for EPI

No hay comentarios:

Publicar un comentario